HIGHLIGHTS
- who: Vasiliki Stravokefalou et al. from the University of Pittsburgh, United States have published the research: Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC, in the Journal: (JOURNAL)
- what: The authors examined the anti-metastatic effects of the treatment by monitoring the presence of metastatic tumor cells in both blood and lungs. The study evaluates for the first time the therapeutic effect of hetIL-15 in combination with Breast cancer is the leading cause of cancer-related deaths in women globally . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.